Article
Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker
20 Dec 2022
Abstract excerpt
Background. Glioma is the most prevalent malignant brain tumor in adult humans, and glioblastoma (GBM) is the most malignant type. The actin-binding LIM 1 (ABLIM1) protein can modulate actin polymerization, which is essential for the cell proliferation and migration. We aim to investigate ABLIM1 expression, function, and clinical significance in GBM. Methods. The ABLIM1 mRNA level was extracted from the TCGA and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
